These findings confirmed that the observed ANT2 shRNA-induced sensitization of breast cancer cells to TRAIL was caused by specific suppression of ANT2 rather than by unforeseen effects of ANT2 shRNA on other genes. The gene discussed is TNFSF10; the disease is breast cancer.